Life Cycle Investment Partners Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 2072459
LONDON, X0
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,287,950
New position
Shares Held
126,308
first reported quarter
Ownership
0.124%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#106
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Life Cycle Investment Partners Ltd holds $32,293,600 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (65.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
126,308 | $21,287,950 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,312 | $11,005,650 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,287,950 | 126,308 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||